The Great COVID-19 Vaccines to the Rescue Hoax. “Making A Billion Dollars” vs. “Harmful Side Effects”


Instead of serving the public interest by reporting truthfully on major issues, establishment media serve as press agents for powerful interests.

Their managed news misinformation and disinformation includes the myth of barbarians at the gates to support endless wars on nations threatening no one, along with handouts to Wall Street and other corporate favorites — notably Big Pharma.

US pharmaceutical and biotech companies have gotten billions of taxpayer dollars to finance their research — drugs developed sold to US consumers at unacceptably high prices.

In 2017, attorney James Young involved in Big Pharma litigation, health fraud, and consumer protection, asked:

“How do we make $1 billion?”

“Big Pharma’s focus on profits often comes at the expense of patient safety,” he added.

“If there is no disease criteria consistent with the symptoms that a company’s drug treats, then the company creates a disease” or a pretext to use its drugs for maximum profits.

“They pay physicians, research institutions, and universities to come up with different disease criteria that are consistent with the symptoms that the drug treats.”

While required to inform consumers of possible harmful side effects, at times they’re hidden, including results of clinical trials.

Making “a billion dollars” requires selling a drug “to a broad market.” Promotion is key, especially by television advertising and getting physician endorsements.

Other methods are also used to market drugs, including unsafe ones, notably vaccines.

All vaccines are hazardous to human health, often causing diseases they’re supposed to protect against.

Even the WHO admitted that more polio cases were caused by vaccines than from the virus itself.

When available, the risk will be extremely high that COVID-19 vaccines may cause serious health problems to individuals permitting themselves to be vaxxed.

At this time, no drugs exist to cure COVID-19, hydroxychloroquine a promising exception.

It’s an anti-malarial drug around for decades that showed positive results in treating COVID-19 patients.

Big Pharma and Bill Gates, in cahoots with Anthony Fauci and other corrupt officials it bribed to support its agenda, want nothing interfering with their diabolical plot to mass-vax humanity with toxins able to kill or otherwise seriously harm human health — substances to be included in a COVID-19 drug when available.

Vaccine development takes around three to four years. Most clinical trials fail.

Pharmaceutical and biotech companies are racing to develop COVID-19 vaccines because of the potential profit bonanza.

Instead of following vaccine development protocol, they’re cutting corners at the expense of safety and efficacy.

It’s virtually impossible to develop a vaccine in months as opposed to required years of testing.

Among others, two companies in the news are Germany’s CureVac and Massachusetts-based Moderna.

Thailand Medical News (TMN) reported that “CureVac’s CEO resigned, and the company received a huge public investment, with the promise to deliver a vaccine by autumn 2020,” adding:

“CureVac’s promises for a different vaccine ended up with nothing to show for but a failed phase 2 clinical trial.”

Moderna began human trials “without any previous preclinical testing for efficacy or safety,” TMN explained.

At least three individuals involved as test subjects for its COVID-19 vaccine had adverse reactions.

One individual said he developed a 103 degree temperature and needed urgent medical treatment.

Potential longer-term hazards to his health remain to be discovered.

TMN noted that Moderna never successfully brought a drug to market through required clinical trials.

According to vaccine experts, the company failed to disclose data on its vaccine development, focusing instead on non-specific PR information to the public.

TMN criticized its approach, calling it “words, not data,” the latter what science requires.

Moderna reportedly enlisted 45 test subjects for its phase 1 trial, publicly reporting early results on 8 alone. What about the other 37?

According to vaccine researcher Dr. Anna Durbin, “(w)e don’t know if (reported) antibodies (in 8 subjects) are durable?”

When asked for more data on its test results, Moderna’s communications director Colleen Hussey said disclosure will come later — in what form and how detailed not explained.

According to TMN, the company “doesn’t publish on its work in scientific journals.”

“What is known has been disclosed through press releases. That’s not enough to generate confidence within the scientific community.”

Separately in mid-May, Pompeo said the Trump regime is “committed” to holding China accountable for widespread COVID-19 outbreaks and deaths it had nothing to do with.

Blaming others for its own wrongdoing is longstanding US policy, including nations victimized by US aggression.

Trump regime hostility toward China ignited a new Cold War that could turn hot if Washington pushes things too far.


Note to readers: please click the share buttons below. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.

Award-winning author Stephen Lendman lives in Chicago. He can be reached at [email protected]. He is a Research Associate of the Centre for Research on Globalization (CRG)

His new book as editor and contributor is titled “Flashpoint in Ukraine: US Drive for Hegemony Risks WW III.”

Visit his blog site at

Comment on Global Research Articles on our Facebook page

Become a Member of Global Research

Articles by: Stephen Lendman

About the author:

Stephen Lendman lives in Chicago. He can be reached at [email protected] His new book as editor and contributor is titled "Flashpoint in Ukraine: US Drive for Hegemony Risks WW III." Visit his blog site at Listen to cutting-edge discussions with distinguished guests on the Progressive Radio News Hour on the Progressive Radio Network. It airs three times weekly: live on Sundays at 1PM Central time plus two prerecorded archived programs.

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected] contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]